Dabigatran etexilate and risk of myocardial infarction, other cardiovascular events, major bleeding, and all-cause mortality: a systematic review and meta-analysis of randomized controlled trials.

<h4>Background</h4>Signals of an increased risk of myocardial infarction (MI) have been identified with dabigatran etexilate in randomized controlled trials (RCTs).<h4>Methods and resules</h4>We conducted searches of the published literature and a clinical trials registry maintained by the drug manu... View More